Press conference regarding Daiichi Sankyo mRNA vaccine "Daichirona intramuscular injection

Press conference regarding Daiichi Sankyo mRNA vaccine "Daichirona intramuscular injection. From left: Shoji Hirashima, Senior Managing Executive Officer; Hiroyuki Okuzawa, President; Wataru Takasaki, Managing Executive Officer. =Date:November 28, 2023, Place:Tokyo

• Product Code
• ILEA002035660

• Registered date
• 2023/11/28 00:00:00

• Credit
• THE NIKKAN KOGYO SHIMBUN / Kyodo News Images

• Media source
• THE NIKKAN KOGYO SHIMBUN

• Media size
• 4500 × 3000 pixel

• Resolution
• 1016 dpi

• Deployment size
• 2.47(MB)*

• Special instruction
• **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.